These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33573495)

  • 21. Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
    Fitzgerald RH; Sabolinski ML; Skornicki M
    Wound Manag Prev; 2019 Sep; 65(9):26-34. PubMed ID: 31702990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of hypothermically stored amniotic membrane on diabetic foot ulcers: a multicentre retrospective case series.
    Sanchez A; Hartstein A; Ashry H; Raza M
    J Wound Care; 2024 Mar; 33(Sup3):S16-S23. PubMed ID: 38457306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.
    Galiano R; Snyder R; Mayer P; Rogers LC; Alvarez O;
    J Wound Care; 2019 Jun; 28(6):383-395. PubMed ID: 31166864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft.
    Sanders L; Landsman AS; Landsman A; Keller N; Cook J; Cook E; Hopson M
    Ostomy Wound Manage; 2014 Sep; 60(9):26-38. PubMed ID: 25211605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryopreserved Placental Membrane Allograft Reduces the Likelihood of Developing a New or Recurring Foot Ulcer and All-Cause Mortality in Diabetic Patients When Compared with Other Cellular- and Tissue-Based Products.
    DaVanzo J; Hartzman A; Surfield C; Dobson A
    Adv Wound Care (New Rochelle); 2023 Apr; 12(4):169-176. PubMed ID: 35262428
    [No Abstract]   [Full Text] [Related]  

  • 27. Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting: a prospective pilot study.
    Yao M; Attalla K; Ren Y; French MA; Driver VR
    J Am Podiatr Med Assoc; 2013; 103(4):274-80. PubMed ID: 23878379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
    Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
    Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary wound closure of diabetic foot ulcers by debridement and stitching.
    Ahmed ME; Mohammed MS; Mahadi SI
    J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic keratinocyte for intractable chronic diabetic foot ulcers: A prospective observational study.
    Hwang YG; Lee JW; Park KH; Han SH
    Int Wound J; 2019 Apr; 16(2):486-491. PubMed ID: 30604568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
    Henshaw FR; Bolton T; Nube V; Hood A; Veldhoen D; Pfrunder L; McKew GL; Macleod C; McLennan SV; Twigg SM
    J Diabetes Complications; 2014; 28(6):850-7. PubMed ID: 25239451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of a polyhydrated ionogen impregnated dressing in the treatment of recalcitrant diabetic foot ulcers: a multi-centre pilot study.
    Pirayesh A; Dessy LA; Rogge FJ; Hoeksema HJ; Sinove YM; Dall' Antonia A; Jawad MA; Gilbert PM; Rubino C; Scuderi N; Blondeel R; Monstrey S
    Acta Chir Belg; 2007; 107(6):675-81. PubMed ID: 18274183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative pressure wound therapy, artificial skin and autogenous skin implantation in diabetic foot ulcers.
    Chia-Jui H; Yu L; Jiang YQ; Tan W; Gao GM; Li HB; Han L
    J Wound Care; 2022 Jan; 31(1):40-46. PubMed ID: 35077212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: A randomized controlled study.
    Maranna H; Lal P; Mishra A; Bains L; Sawant G; Bhatia R; Kumar P; Beg MY
    Diabetes Metab Syndr; 2021; 15(1):365-371. PubMed ID: 33524646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot feasibility study of non-cultured autologous skin cell suspension for healing diabetic foot ulcers.
    Rashid ST; Cavale N; Bowling FL
    Wound Repair Regen; 2020 Nov; 28(6):719-727. PubMed ID: 32686262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicentre clinical trial evaluating the outcomes of two application regimens of a unique keratin-based graft in the treatment of Wagner grade one non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Carter MJ; Hanft J; Surprenant M; Isaac AL; Zelen CM
    Int Wound J; 2024 Sep; 21(9):e70029. PubMed ID: 39245798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study.
    Löndahl M; Tarnow L; Karlsmark T; Lundquist R; Nielsen AM; Michelsen M; Nilsson A; Zakrzewski M; Jörgensen B
    J Wound Care; 2015 Apr; 24(4):172-4, 176-8. PubMed ID: 25853474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a novel purified reconstituted bilayer matrix for treatment of chronic diabetic foot ulcers: a retrospective case series.
    Isaac AL; Tritto M
    Wounds; 2023 Jan; 35(1):E29-E34. PubMed ID: 36749995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study.
    Niederauer MQ; Michalek JE; Liu Q; Papas KK; Lavery LA; Armstrong DG
    J Wound Care; 2018 Sep; 27(Sup9):S30-S45. PubMed ID: 30207844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
    Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
    J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.